Adjuvant therapy of primary breast cancer VI

En savoir plus sur le livre

This RRCR-conference volume represents the sixth installment in a 20-year journey of international conferences focused on the adjuvant therapy of primary breast cancer. Beginning in 1978, around 80 dedicated breast cancer surgeons and oncologists convened in a secluded Swiss mountain resort to share early data from pioneering trials on adjuvant systemic therapy. Their aim was to address the stagnation in prognosis for this prevalent disease among Western women. Held every 3-4 years, the St. Gallen International Conferences have expanded significantly, both in participant numbers and in their influence on therapeutic norms, with findings published in major oncology journals. The most recent conference, from February 25-28, 1998, attracted over 1800 attendees from more than 50 countries. The ongoing interest in adjuvant therapy for early breast cancer raises questions about the developments over the past three years that warrant such a large gathering of leading experts. Enhancing care and formulating effective recommendations for patients with early breast cancer or those at high risk remain crucial public health objectives.